Skip to main content
logo
Dishman Carbogen Amcis Limited (NSE:DCAL)
India flag India · Delayed Price · Currency is INR
180.24
-4.40 (-2.38%)
Jun 15, 2026, 3:29 PM IST

Dishman Carbogen Amcis Revenue

In the fiscal year ending March 31, 2026, Dishman Carbogen Amcis had annual revenue of 29.32B INR with 8.13% growth. Dishman Carbogen Amcis had revenue of 8.51B in the quarter ending March 31, 2026, with 18.85% growth.

Revenue
29.32B
Revenue Growth
+8.13%
P/S Ratio
0.96
Revenue / Employee
26.51M
Employees
1,106
Market Cap
28.26B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202629.32B2.20B8.13%
Mar 31, 202527.12B957.30M3.66%
Mar 31, 202426.16B2.03B8.41%
Mar 31, 202324.13B2.72B12.72%
Mar 31, 202221.41B2.29B11.96%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Biocon169.27B
Anthem Biosciences21.24B
OneSource Specialty Pharma14.22B
Concord Biotech10.55B
Blue Jet Healthcare9.47B
Supriya Lifescience8.28B
Panacea Biotec6.40B
Zota Health Care5.39B
Revenue Rankings

Dishman Carbogen Amcis News

More News